Trials / Unknown
UnknownNCT01845324
Fetal Heart Interventricular Septum in Fetuses of Diabetic Mothers
Relation Between Fetal Heart Interventricular Septum Size and Gestational Diabetes Mellitus Control. a Prospective Trial
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The investigators asume that the measurement of the fetal heart interventricular septum can serve as a good tool to predict glucose control in pregnant patients with diabetes mellitus. The investigators will measure the septum width in patients with Diabetes and will correlate to standard measurements of the glucuse levels.
Detailed description
In this study the investigators will follow patients with Diabetes Mellitus - mainly gestational. the investigators will measure the width of the interventricular septum and correlate with conventional measures of blood glucose measurements in this population. The investigators will try to assess whether measurement of the septum can be an earlier and better predictor of glucose control in this population.
Conditions
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-05-01
- Completion
- 2014-06-01
- First posted
- 2013-05-03
- Last updated
- 2013-05-03
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01845324. Inclusion in this directory is not an endorsement.